• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在生物反应器培养的中国仓鼠卵巢细胞中产生的聚集抗体的糖基化分析。

Glycosylation analysis of an aggregated antibody produced by Chinese hamster ovary cells in bioreactor culture.

机构信息

Institute of Technology and Science, The University of Tokushima, Minamijosanjima-cho 2-1, Tokushima 770-8506, Japan.

Department of Biotechnology, Graduate School of Engineering, Osaka University, Yamadaoka 2-1, Suita, Osaka 565-0871, Japan.

出版信息

J Biosci Bioeng. 2014 May;117(5):639-44. doi: 10.1016/j.jbiosc.2013.11.001. Epub 2013 Dec 8.

DOI:10.1016/j.jbiosc.2013.11.001
PMID:24326352
Abstract

N-Glycosylation of therapeutic antibodies contributes not only to their biological function, but also to their stability and tendency to aggregate. Here, we investigated the impact of the glycosylation status of an aggregated antibody that accumulated during the bioreactor culture of Chinese hamster ovary cells. High-performance liquid chromatography analysis showed that there was no apparent difference in the glycosylation patterns of monomeric, dimeric, and large aggregated forms of the antibody. In contrast, lectin binding assays, which enable the total amounts of specific sugar residues to be detected, showed that both galactose and fucose residues in dimers and large aggregates were reduced to 70-80% of the amount in monomers. These results strongly suggest that the lack of N-linked oligosaccharides, a result of deglycosylation or aglycosylation, occurred in a proportion of the dimeric and large aggregated components. The present study demonstrates that glycosylation heterogeneities are a potential cause of antibody aggregation in cell culture of Chinese hamster ovary cells, and that the lack of N-glycosylation promotes the formation of dimers and finally results in large aggregates.

摘要

N-糖基化不仅影响治疗性抗体的生物学功能,也影响其稳定性和聚集倾向。在这里,我们研究了在仓鼠卵巢细胞生物反应器培养过程中积累的聚集抗体的糖基化状态的影响。高效液相色谱分析表明,抗体的单体、二聚体和大聚集形式之间的糖基化模式没有明显差异。相比之下,凝集素结合测定法可以检测到特定糖残基的总量,结果表明二聚体和大聚集体中的半乳糖和岩藻糖残基减少到单体中糖残基数量的 70-80%。这些结果强烈表明,在二聚体和大聚集成分中,存在 N 连接寡糖的缺失,这是脱糖基化或无糖基化的结果。本研究表明,糖基化异质性是仓鼠卵巢细胞培养中抗体聚集的一个潜在原因,并且 N-糖基化的缺失促进了二聚体的形成,最终导致了大聚集体的形成。

相似文献

1
Glycosylation analysis of an aggregated antibody produced by Chinese hamster ovary cells in bioreactor culture.在生物反应器培养的中国仓鼠卵巢细胞中产生的聚集抗体的糖基化分析。
J Biosci Bioeng. 2014 May;117(5):639-44. doi: 10.1016/j.jbiosc.2013.11.001. Epub 2013 Dec 8.
2
Trehalose suppresses antibody aggregation during the culture of Chinese hamster ovary cells.海藻糖可抑制中国仓鼠卵巢细胞培养过程中的抗体聚集。
J Biosci Bioeng. 2014 May;117(5):632-8. doi: 10.1016/j.jbiosc.2013.10.022. Epub 2013 Dec 4.
3
Glycosylation pattern of humanized IgG-like bispecific antibody produced by recombinant CHO cells.人源化 IgG 样双特异性抗体在重组 CHO 细胞中的糖基化模式。
Appl Microbiol Biotechnol. 2010 Jan;85(3):535-42. doi: 10.1007/s00253-009-2152-z. Epub 2009 Aug 4.
4
Culture temperature modulates half antibody and aggregate formation in a Chinese hamster ovary cell line expressing a bispecific antibody.培养温度调节表达双特异性抗体的中国仓鼠卵巢细胞系中半抗体和聚集体的形成。
Biotechnol Bioeng. 2018 Dec;115(12):2930-2940. doi: 10.1002/bit.26803. Epub 2018 Oct 5.
5
Secretory leakage of IgG1 aggregates from recombinant Chinese hamster ovary cells.重组中国仓鼠卵巢细胞中IgG1聚集体的分泌性泄漏
J Biosci Bioeng. 2019 Jun;127(6):752-757. doi: 10.1016/j.jbiosc.2018.11.015. Epub 2018 Dec 21.
6
An efficient method to control high mannose and core fucose levels in glycosylated antibody production using deoxymannojirimycin.使用去氧甘露糖基己氨酸有效控制糖基化抗体生产中高甘露糖和核心岩藻糖的水平。
J Biotechnol. 2018 Jun 20;276-277:54-62. doi: 10.1016/j.jbiotec.2018.04.006. Epub 2018 Apr 16.
7
Interaction of cell culture process parameters for modulating mAb afucosylation.细胞培养工艺参数的相互作用调节单抗去岩藻糖化。
Biotechnol Bioeng. 2019 Apr;116(4):831-845. doi: 10.1002/bit.26908. Epub 2019 Feb 4.
8
Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System.使用自动化微生物反应器系统从中国仓鼠卵巢细胞中纯化和分析单克隆抗体
J Vis Exp. 2019 May 1(147). doi: 10.3791/58947.
9
Impact of cell culture media additives on IgG glycosylation produced in Chinese hamster ovary cells.细胞培养添加物对中国仓鼠卵巢细胞产生的 IgG 糖基化的影响。
Biotechnol Bioeng. 2019 Apr;116(4):816-830. doi: 10.1002/bit.26904. Epub 2019 Jan 21.
10
Advances in analytical methodologies to guide bioprocess engineering for bio-therapeutics.指导生物治疗药物生物过程工程的分析方法进展。
Methods. 2017 Mar 1;116:63-83. doi: 10.1016/j.ymeth.2016.11.002. Epub 2016 Nov 8.

引用本文的文献

1
Enhancing recombinant antibody yield in Chinese hamster ovary cells.提高中国仓鼠卵巢细胞中重组抗体的产量。
Tzu Chi Med J. 2024 May 24;36(3):240-250. doi: 10.4103/tcmj.tcmj_315_23. eCollection 2024 Jul-Sep.
2
Decreasing hydrophobicity or shielding hydrophobic areas of CH2 attenuates low pH-induced IgG4 aggregation.降低CH2的疏水性或屏蔽其疏水区域可减弱低pH诱导的IgG4聚集。
Front Bioeng Biotechnol. 2023 Aug 29;11:1257665. doi: 10.3389/fbioe.2023.1257665. eCollection 2023.
3
Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors.
双特异性抗体:治疗实体瘤的新方法。
Pharmaceutics. 2022 Nov 11;14(11):2442. doi: 10.3390/pharmaceutics14112442.
4
Aggregation of protein therapeutics enhances their immunogenicity: causes and mitigation strategies.蛋白质治疗药物的聚集增强了它们的免疫原性:原因及缓解策略。
RSC Chem Biol. 2021 May 4;2(4):1004-1020. doi: 10.1039/d1cb00067e. eCollection 2021 Aug 5.
5
Macro- and Micro-Heterogeneity of Natural and Recombinant IgG Antibodies.天然和重组IgG抗体的宏观和微观异质性
Antibodies (Basel). 2019 Feb 19;8(1):18. doi: 10.3390/antib8010018.
6
Structure, heterogeneity and developability assessment of therapeutic antibodies.治疗性抗体的结构、异质性和可开发性评估。
MAbs. 2019 Feb/Mar;11(2):239-264. doi: 10.1080/19420862.2018.1553476. Epub 2018 Dec 17.
7
Analytical comparability study of recombinant monoclonal antibody therapeutics.重组单克隆抗体治疗药物的分析可比性研究。
MAbs. 2018 May/Jun;10(4):513-538. doi: 10.1080/19420862.2018.1438797. Epub 2018 Mar 20.
8
Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics.具有优化物理化学性质的Fc片段工程,意味着基于Fc的治疗药物临床潜力的提升。
Front Immunol. 2018 Jan 8;8:1860. doi: 10.3389/fimmu.2017.01860. eCollection 2017.
9
Animal Cell Expression Systems.动物细胞表达系统。
Adv Biochem Eng Biotechnol. 2021;175:1-36. doi: 10.1007/10_2017_31.
10
Bispecific antibodies and their applications.双特异性抗体及其应用。
J Hematol Oncol. 2015 Dec 21;8:130. doi: 10.1186/s13045-015-0227-0.